AVDL
Avadel Pharmaceuticals plc · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website avadel.com
- Employees(FY) 41
- ISIN nan
Performance
-10.52%
1W
-2.64%
1M
+10.47%
3M
+56.55%
6M
+15.08%
YTD
+9.5%
1Y
Profile
Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is LUMRYZ, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness or cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and changed its name to Avadel Pharmaceuticals plc in January 2017. Avadel Pharmaceuticals plc was incorporated in 2015 and is headquartered in Dublin, Ireland.
Investment Analysis Report: AVDL
Overview
AVDL is a pharmaceutical company operating in the Health Technology sector, specifically in the Pharmaceuticals: Major industry. The company has a market capitalization of $1.22 billion. In this report, we will conduct a comprehensive analysis of AVDL's financial statements to evaluate its financial heal...
Technical Analysis of AVDL 2024-05-03
Overview:
In analyzing the technical indicators for AVDL over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.
Trend Analysis:
- Moving Averages (MA): The 5-day Moving Average has been consistently above the closin...
Recent News & Updates
- 2024-05-08 08:36
- 2024-05-08 07:17
Avadel: Q1 Earnings Snapshot(Associated Press Finance)
- 2024-05-08 07:00
- 2024-05-07 19:00
- 2024-05-01 08:00
- 2024-04-30 20:00
- 2024-04-29 09:55
- 2024-04-28 21:55
- 2024-04-21 10:39
11 Best Low Price Pharma Stocks To Invest In(Insider Monkey)
- 2024-04-20 22:39
11 Best Low Price Pharma Stocks To Invest In(Insidermonkey)
- 2024-04-11 06:42
- 2024-04-01 08:00
- 2024-03-31 20:00
- 2024-03-05 10:25
- 2024-03-05 08:00
- 2024-03-04 19:00
- 2024-03-04 15:37
Avadel Pharmaceuticals Issues Statement On Patent Litigation(GlobeNewswire)
- 2024-03-04 06:30
- 2024-03-04 02:37
Avadel Pharmaceuticals Issues Statement On Patent Litigation(Globenewswire)
- 2024-03-03 17:30
- 2024-03-01 08:56
- 2024-02-26 08:00
- 2024-02-25 19:00
- 2024-02-06 19:00
- 2024-02-06 19:00
- 2024-01-18 10:35
- 2024-01-18 08:05
- 2024-01-17 21:35
- 2024-01-17 06:44
Daily – Vickers Top Buyers & Sellers for 01/17/2024(Argus Research)
- 2024-01-15 12:00
Page 1 of 5
previousnext